Amdocs Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -33.0% | -27.3% | +44.3% | +13.8% | -51.6% | +63.4% | +39.9% | -4.7% | -4.2% | -53.9% | +94.1% | – | |
| – | -3.0% | +13.4% | -11.7% | +7.5% | -5.9% | 0.0% | +7.0% | +6.7% | -4.2% | +4.5% | -1.1% | – | |
| – | +5.2% | +1.0% | -0.9% | -0.4% | +2.0% | -3.3% | +1.2% | +3.0% | -9.9% | +57.7% | -43.1% | – | |
| – | -129.0% | – | – | – | -237.9% | – | – | +2,035.3% | -167.9% | – | – | – | |
| – | +64.7% | -55.2% | -16.7% | +58.0% | +6.0% | -41.6% | +84.3% | +6.1% | +3.3% | -34.1% | +19.1% | – | |
| – | +101.5% | -84.6% | – | -180.0% | +527.3% | – | -172.5% | – | -1,192.0% | -84.7% | -32.3% | – | |
| – | -1.4% | -0.7% | +9.6% | -1.5% | -1.1% | -0.7% | +9.1% | -1.1% | -1.4% | -0.8% | +6.6% | – | |
| – | +2.3% | -27.2% | +46.8% | -29.3% | +20.6% | -6.4% | 0.0% | +0.9% | +7.1% | -5.4% | +3.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -7.7% | -75.0% | – | |
| – | -3.1% | -25.3% | +43.6% | -17.5% | +10.2% | -10.0% | +3.6% | +1.7% | -62.4% | +38.8% | +81.0% | – | |
| – | -5,762.2% | – | – | – | -570.7% | – | -40.6% | +189.6% | -233.7% | – | – | – | |
| – | -43.6% | -18.5% | +54.9% | +9.7% | -59.3% | +100.1% | +35.4% | -6.2% | -5.4% | -57.2% | +114.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.